Measurements of plasma renin activity (PRA) in renal vein blood from the ischemic kidney are reported to be generally higher than from the contralateral kidney. Importance of factors other than renin content of renal venous plasma has not been investigated. Initial rate measurements of angiotensin generation with added excess of homologous renin (Plasma Renin Substrate Activity [PRSA]-20 min) were made in bilateral renal venous plasma from 31 patients suspected of suffering from unilateral renal hypertension. The mean values from the involved vs. the contralateral kidney were 551 vs. 331 ng respectively of angiotensin II equivalents generated per milliliter of plasma per 20 min of incubation. The measurement of maximal angiotensin generation under the same conditions with incubation prolonged to 3 hr (PRSA-180 min), however, were bilaterally equal in renal venous plasma from selected patients with renal hypertension who showed distinct differences in PRSA-20 min and PRA measurements. Prior extraction of plasma lipids did not significantly change the bilateral renal venous PRSA-20 min determinations. Stimulation of endogenous renin release in normal dogs did not change the PRSA determinations. The data suggest strongly the presence of a "renin activating" mechanism in the renal venous plasma from the involved kidney of patients with renal hypertension.
INTRODUCTION
Bilateratl measurements of plasma renin activity (PRA') in renal venous blood have significantly aided the identification of the involved or the relatively miiore involved kidney in patients with renal hypertensioni (1) (2) (3) (4) (5) (6) (7) (8) (9) . Varying degree of differential between the two renal venous PRA measuremiients (a ratio ranging from 1.7 to 3 and higher) has been regarded as significant. Unilateral elevation of PRA in the renal vein blood, however, has not been found to be a conistant feature for all p.atients with surgically remediable renal hypertension. OIn the other hand, unilateral elevations of renal vein PRA, presumably unrelated to the hypertensive lprocess, have been noted (3) . The relported incidence of these false negative and false positive determinations has been around 21-37% (3, 8) . Also PRA values from the contralateral renal vein, as well as the peripheral blood in proven cases of renal hypertension, have been described as normiial in some cases and elevated in others (5, 9) . Direct pressor activity measuremiients of the venous effluent from the affected kidney in patients with renal hypertension have been proposed as a diagnostic tool superior to the measurements of renin contenit by one group of investigators (10) . Others found it to be of lesser value ( 11 ) .
In peripheral plasma of normal as well as hypertenlsive subjects, the existence of naturally occurring cofactors of renin reaction has been suggested by several workers (12) (13) (14) who observed a considerable variation in the rate of angiotensin generation in different samples during PRA measurements under constant in vitro conditions. A phospholipid inhibitor of renin, widely distributed in animal tissues and capable of reducing blood pressure of hypertensive animals, has been described (15) (16) (17) . Any possible significance of this inhibitor or 1Abbreviations used in this paper: DFP, diisopropyfluorophosphonate; PRA, plasma renin activity; PRSA, plasma renin substrate activity. 22 The Journal of Clinical Investigation Volume 51 1972 other unknown modifiers of renin-substrate reaction in health or disease, however, remains to be established. It is noteworthy that other investigators (18, 19) , who have discounted the existence of renin cofactors, have used somewhat different methods for renin measurements in plasma that involved addition of exogenous renin substrate and thereby determined renin "concentration" rather than "activity."
In bilateral renal venous plasma from renal hypertensive patients, comparisons of renin activity vs. concentration measurements Genest (12) . In the case of dog plasma, a drop of 1% diisopropylfluorophosphonate (DFP) was added to the incubates in addition. Bioassay techniques for angiotensin using a 16 hr nephrectomized, pentoliniumtreated rat have been described previously (20) .
Renin from human kidneys was prepared according to the methods described by Haas The term PRSA used in the text has the further merit of being analogous to the term PRA used for plasma renin activity. It was neither feasible nor entirely valid to perform conventional enzyme kinetic studies in crude renal venous plasma from individual patients. Instead, we have studied angiotensin generation for two time periods in whole plasma under the imposed conditions of incubation with added excess of angiotensinase-free homologous renin (a) The initial rate measurements with short term incubations for 20 min, termed PRSA-20 min, were selected as a more reliable index of the influence of the enzyme, as well as the substrate concentration on the rate of the reaction (23) . Accordingly, in the presence of added excess of the enzyme, the rate of reaction during these short-term incubations should be proportional to either the available substrate concentrations alone (if no cofactors are operative) or in addition, reflect the influence of any existing modifiers of the rate of the reaction. subjects, plotted vs. levels of added renin (milliliters of preparation used) to determine the quantity of renin required to give maximum angiotensin yield.
Of 3 hr termed PRSA-180 min, were performed with the purpose of equating them, as best as possible under the existing conditions, to the total substrate concentration rather than the rate of renin-substrate reaction.
The volume of the standardized human renin preparation required to yield. maximal rate of angiotensin generation per milliliter of plasma during PRSA measurements ( Fig.  1 ) was generally 0.05 ml and always between 0.05 and 0.1 ml. PRSA-20 min was determined in most of the patients. PRSA-180 min was determined in selected patients.
Routine PRSA measurements were made on nondialysed whole plasma. In many samples of bilateral renal venous plasma effective dialysis against water followed by reconstitution to isotonicity with sodium chloride was shown not to cause significant change in the PRSA determinations. Each experimental period was 30 min. Blood samples were collected before and after each period and processed as described above.
Clinical material. The term involved kidney or the more involved kidney was based both on a higher value of renal venous PRA as well as the available clinical diagnosis.
RESULTS
Initial rate measurements (PRSA-20 min) of angiotensin generation with added excess of renin. Routine PRSA-20 min measurements were performed at plasma pH 5.5 in conformity with measurements of PRA and PRSA-180 min. In several patients PRSA-20 min measurements were repeated at plasma pH of 7.5. PRSA-20 min determinations, compared with each other at the two pH values, were similar in some plasma samples and somewhat different in others. The difference, however, lacked a consistent pattern. The values obtained at the neutral pH were scattered on both sides of those obtained at the acid pH. Nevertheless, existing differences between bilateral renal venous PRSA-20 min noted at the acid pH were also present at the neutral pH and were of similar magnitude.
Measurements of maximal angiotensin generation (PRSA-180 min) with added excess of renin. Five patients with known renovascular hypertension (Fig. 4) were selected on the basis of a marked difference in PRA values between the bilateral renal venous plasma, and PRSA-180 min in renal venous plasma was studied in these patients. As shown in the upper panel of Fig.  4 , there is a very marked (average six to one) difference in the plasma renin activity in the renal venous blood obtained from the two kidneys. In the middle panel (Fig. 4) marked as added renin, PRSA-180 min expressed as nanograms of angiotensin per hour of incubation time, is practically equal in plasma from both renal veins. In the lower panel (Fig. 4) when both renin as well as substrate of human origin were added, angiotensin production again is significantly higher in renal venous plasma from the involved side. Under the 'Available bilateral renal venous plasma was insufficient to perform simultaneous PRA and PRSA determinations in the remaining patients. conditions of added excess of substrate, angiotensin generation can be assumed to be independent of the substrate concentration, and to be theoretically dependent upon the available concentration of enzyme and/or additional influence of "inhibitors" or "accelerators" of the enzymatic reaction. These experiments indicated to us that the observed bilateral diffeernce in PRSA-20 min values shown in Fig. 2 in the renal venous plasma is probably not attributable to a difference in the concentration of renin substrate. Additional confirmatory studies, determining PRSA-20 min and PRSA-180 min simultaneously in the same subject, however, were required. The studies on 11 patients listed in Table I further support these findings. The mean of PRSA-20 min measurements was 739 ng angiotensin/ml plasma per 20 min in the renal venous blood from the presumably "involved" kidney (Table I) , and 509 ng/ml per 20 min from the contralateral kidney. The mean of PRSA-180 min expressed as nanograms angiotensin per milliliter per 3 hr however was 1340 and 1432 respectively. Excluding the patients with bilateral disease (patients No. 6, 10, and 11, marked with asterisk in Table I ) the mean values for PRSA-20 min in the remaining eight patients with predominantly unilateral disease were 616 ng/ml and 337 ng/ml, respectively in the effluent of the more involved and the less involved contralateral kidney. The mean of the corresponding figures for PRSA 180 min for the two kidneys remained 1506 ng/ml and 1630 ng/ml respectively. 4 Angiotensin production ( Since these results were obtained by the addition of exogenous renin to bilateral renal venous plasma, they also preclude the necessity to postulate a primary change in the nature of the endogenous renin molecule secreted by the ischemic kidney. Furthermore, the animal experiments (Fig. 5) showed that even induced elevations of endogenous renin content of plasma within the biologic range do not increase the determined value of PRSA. These studies on dogs further indicated that the release of a hypothetical "activator" or the induction of an activating mechanism for renin is not related to the physiologic mechanisms of renin release.
Renin Activation in Hypertension
Most of our in vitro studies were performed on whole undialysed plasma, and it may be questioned if the demonstrated bilateral renal venous difference in PRSA-20 min significantly depends upon a higher content of preformed pressor materials in the plasma from the ischemic kidney (10, 25) . Any contribution of preexisting materials in whole plasma to the values of generated angiotensin produced during PRSA-20 min determinations (range 200-1200 ng/ml plasma) becomes negligible when the comparative amounts involved are considered. Gocke, Gerten, Sherwood, and Laragh (25) demonstrated a higher content of angiotensin II in the renal venous plasma from the ischemic than the contralateral kidneys of patients with hypertension. The highest value per 1 ml of plasma of angiotensin II detected in these studies was 1 ng. Grollman and Ebihara (10) described the presence, in the renal venous plasma from the ischemic kidney, of an "angiotensin I-like" pressor material presumably bound to protein and not subject to dialysis. The pressor effect of directly injected crude plasma considered significant in these studies ranged from 5 to 12 ng equivalents of angiotensin II per milliliter plasma.
The influence of any preexisting pressor materials, therefore, on PRSA-20 min determinations can be discounted as insignificant. These materials, on the other hand, when present may very well account for a significant part of the difference in bilateral renal venous PRA determinations.
Since the importance of the enzyme (renin) content is mitigated by the considerations discussed earlier, the content of renin substrate in the bilateral renal venous plasma could be considered as the prime determinant of the level of angiotensin production during PRSA-20 min measurements. The results, however, do not support this assumption. Measurements of PRSA-180 min were not significantly different in bilateral renal venous plasma from patients with renal hypertension (Fig. 4 , Table I ).
The data presented strongly suggest that an undefined "renin activating mechanism" is originating in the ischemic kidney. The mechanism may rapidly exhaust itself in vitro and be reflected only in initial rate measurements. Experiments shown in Fig. 4 (lower panel) , however, do not support this suggestion.
The possible mechnisms to be considered are: (a) elaboration of a protein activator of renin; (b) induction of molecular changes in renin substrate so as to favor an acceleration of the renin reaction. Future work using methods of improved sensitivity and specificity is required.
The above considerations further suggest that the bilateral disparity of renal venous PRA determinations observed in patients with renal hypertension may not always reflect a true difference in renin content but rather depend considerably on some of the same factors discussed here that seem to determine the disparity of PRSA-20 min measurements. In this regard, however, a possible role of the contralateral "normal" kidney still remains to be elucidated. The not so infrequent finding of a renal venous PRA measurement or PRSA-20 min determination (Table I ) from the contralateral kidney being lower than the value obtained in plasma from the low inferior vena cava, has not been explained. Renin destruction by the contralateral kidney, elaboration of a renin inhibitor (other than extractable plasma lipids), and inactivation of a renin activator remain theoretical possibilities.
